Noble Capital Markets Emerging Growth Virtual Equity Conference 2025 – Presentation Replays

5/5/2025

Business

0 min read

Watch the replays from the Noble Capital Markets Emerging Growth Virtual Equity Conference. Replays are available to Channelchek registered members. Registration is free and easy. Simply click the Join button in the upper right to get started.

Day 1 Replays

**Connect Biopharma (CNTB)**
**Watch the Replay**

**Charles River Associates (CRAI)**
**Watch the Replay**

**Eledon Pharmaceuticals (ELDN)**
**Watch the Replay**

**Euroseas (ESEA)**
**Watch the Replay**

**The ONE Group (STKS)**
**Watch the Replay**

**Steelcase (SCS)**
**Watch the Replay**

**GoHealth (GOCO)**
**Watch the Replay**

**Unicycive Therapeutics (UNCY)**
**Watch the Replay**

**Townsquare Media (TSQ)**
**Watch the Replay**

**Greenwich LifeSciences (GLSI)**
**Watch the Replay**

**CBL International (BANL)**
**Watch the Replay**

**Twin Hospitality Group (TWNP)**
**Watch the Replay**

**Flushing Financial (FFIC)**
**Watch the Replay**

Day 2 Replays

**Sigma Lithium (SGML)**
**Watch the Replay**

**BioLargo Inc. (BLGO)**
**Watch the Replay**

**SKYX Platforms (SKYX)**
**Watch the Replay**

**Titan International (TWI)**
**Watch the Replay**

**Superior Group of Companies** **Watch the Replay**

**CoreCivic (CXW)**
**Watch the Replay**

**Brilliant Earth Group (BRLT)**
**Watch the Replay**

**Cocrystal Pharma (COCP)**
**Watch the Replay**

**Sky Harbour Group (SKYH)**
**Watch the Replay**

**FAT Brands (FAT)**
**Watch the Replay**

**Lottery.com (LTRY)**
**Watch the Replay**

**SBC Medical Group (SBC)**
**Watch the Replay**

**Kalaris Therpeutics (KLRS)**
**Watch the Replay**

**Nutriband (NTRB)**
**Watch the Replay**

Participating in 1×1 Meetings Only

Access to Exclusive Content. FREE for Registered Users Only.

Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.

‌

The site "channelcheck" is opened on the phone

Welcome to the Channelchek Investor Community

We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.

Don't have an account? Join

Forgot password

By clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.

Release – GeoVax Comments on FDA Approval of Keytruda® in Head and Neck Cancer, Underscoring Potential for Gedeptin® Combination Therapy

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today commented on the U.S. Food and Drug Administration’s recent approval...

6 min read

‌

Release – ARK Demonstrates Robust June Momentum as Snail Games Celebrates 10-Year Anniversary and Prepares for Aquatica DLC Launch

6/24/2025

Media and Entertainment

Release – ARK Demonstrates Robust June Momentum as Snail Games Celebrates 10-Year Anniversary and Prepares for Aquatica DLC Launch

Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, celebrates the ARK franchise’s 10-year anniversary with strong June 2025 sales...

4 min read

‌

Fed in No Rush: Powell Stands Firm as Trump Pushes for Rate Cuts

6/24/2025

Economy

Fed in No Rush: Powell Stands Firm as Trump Pushes for Rate Cuts

Federal Reserve Chair Jerome Powell has reaffirmed the central bank’s cautious stance on interest rate policy, signaling that the Fed is in no rush to cut rates as it awaits...

3 min read

‌

Release – MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board

6/24/2025

Health

Release – MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board

MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced the appointment of two prominent oncologists to its...

6 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

NewsMorning ResearchVideos

By clicking submit you are agreeing to the Terms of Use and Privacy Policy